FXR, a multipurpose nuclear receptor.
暂无分享,去创建一个
Yanqiao Zhang | P. Edwards | Hans Lee | Yanqiao Zhang | Peter A Edwards | F. Lee | Hans Lee | Florence Y Lee | Melissa L Hubbert | Melissa L. Hubbert
[1] T. Willson,et al. Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor* , 2003, Journal of Biological Chemistry.
[2] P. Nestel,et al. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. , 1974, Lancet.
[3] A. Morelli,et al. Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis , 2005, Journal of Pharmacology and Experimental Therapeutics.
[4] B. Chatterjee,et al. Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor* , 2001, The Journal of Biological Chemistry.
[5] S. Friedman,et al. Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.
[6] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[7] S. Kliewer,et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.
[8] S. Kliewer,et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Lewis,et al. Serum Lipids in Cholelithiasis: Effect of Chenodeoxycholic Acid Therapy , 1973, British medical journal.
[10] R. Evans,et al. The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity* , 2004, Journal of Biological Chemistry.
[11] Richard J. Thompson,et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. , 2004, Gastroenterology.
[12] R. Sato,et al. Bile Acid Reduces the Secretion of Very Low Density Lipoprotein by Repressing Microsomal Triglyceride Transfer Protein Gene Expression Mediated by Hepatocyte Nuclear Factor-4* , 2004, Journal of Biological Chemistry.
[13] D. Mangelsdorf,et al. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. , 2006, Annual review of physiology.
[14] T. Willson,et al. The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily. , 2003, Nucleic acids research.
[15] J. Chiang,et al. Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα) , 2001 .
[16] J. Auwerx,et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.
[17] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[18] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[19] L. Moore,et al. Identification of a chemical tool for the orphan nuclear receptor FXR. , 2000, Journal of medicinal chemistry.
[20] M. Karin,et al. Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.
[21] G. Burckhardt,et al. Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro. , 1981, The Journal of clinical investigation.
[22] Bryan Goodwin,et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.
[23] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[24] Jasmine Chen,et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.
[25] E. Njolito,et al. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor. , 2000, Toxicology and applied pharmacology.
[26] B. Staels,et al. Glucose regulates the expression of the farnesoid X receptor in liver. , 2004, Diabetes.
[27] Giovanni Galli,et al. Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.
[28] D. Russell,et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.
[29] Masataka Harada,et al. A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.
[30] B. Staels,et al. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. , 2003, Gastroenterology.
[31] A. Bookout,et al. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model , 2004, Nature Medicine.
[32] A. Fukamizu,et al. Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.
[33] P. Young,et al. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. , 2002, Gene.
[34] P. Edwards,et al. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR , 2004 .
[35] C. J. Sinal,et al. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice Published, JLR Papers in Press, September 26, 2005. DOI 10.1194/jlr.M500390-JLR200 , 2005, Journal of Lipid Research.
[36] A. Anisfeld,et al. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. , 2002, Journal of lipid research.
[37] P. Edwards,et al. FXR Deficiency Causes Reduced Atherosclerosis in Ldlr−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[38] D. Moore,et al. An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.
[39] T. Willson,et al. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. , 2001, Molecular endocrinology.
[40] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[41] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[42] A. Grefhorst,et al. Transient impairment of the adaptive response to fasting in FXR‐deficient mice , 2005, FEBS letters.
[43] S. Kliewer,et al. Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.
[44] Sander M Houten,et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. , 2004, The Journal of clinical investigation.
[45] A. Morelli,et al. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. , 2004, Gastroenterology.
[46] R. Savkur,et al. Regulation of carbohydrate metabolism by the farnesoid X receptor. , 2005, Endocrinology.
[47] M. Makishima,et al. Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.
[48] D. Moore,et al. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.
[49] N. Mitro,et al. The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. , 2001, The Journal of biological chemistry.
[50] R. Willén,et al. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. , 1993, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.
[51] G. Churchill,et al. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. , 2003, Gastroenterology.
[52] Jasmine Chen,et al. Identification of a nuclear receptor that is activated by farnesol metabolites , 1995, Cell.
[53] M. Haussler,et al. Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.
[54] Timothy M Willson,et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] Roger A. Davis,et al. Regulation of cholesterol-7α-hydroxylase: BAREly missing a SHP , 2002 .
[56] R. Tangirala,et al. Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation* , 2003, Journal of Biological Chemistry.
[57] M. Makishima,et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.
[58] Folkert Kuipers,et al. The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice* , 2006, Journal of Biological Chemistry.
[59] M. Bowman,et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. , 2003, Molecular cell.
[60] D. Russell. The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.
[61] Heidi R. Kast-Woelbern,et al. A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids Published, JLR Papers in Press, November 3, 2005. , 2006, Journal of Lipid Research.
[62] S. Kliewer,et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[63] P. Dent,et al. Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[64] R. Blevins,et al. Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3* , 2003, Journal of Biological Chemistry.
[65] P. Meier,et al. Hepatocellular transporters and cholestasis. , 2005, Journal of clinical gastroenterology.
[66] B. Staels,et al. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[67] J. Auwerx,et al. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. , 2002, Molecular endocrinology.
[68] M. Fishbein,et al. α-Crystallin Is a Target Gene of the Farnesoid X-activated Receptor in Human Livers* , 2005, Journal of Biological Chemistry.
[69] Jasmine Chen,et al. Identification of Gene-selective Modulators of the Bile Acid Receptor FXR* , 2003, The Journal of Biological Chemistry.
[70] Roger A. Davis,et al. Bile Acids Decrease Hepatic Paraoxonase 1 Expression and Plasma High-Density Lipoprotein Levels Via FXR-Mediated Signaling of FGFR4 , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[71] D. Mangelsdorf,et al. A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR , 2002, Science.
[72] P. Dawson,et al. Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids , 2006 .
[73] P. Dawson,et al. The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.
[74] D. Mangelsdorf,et al. Pregnane X Receptor Is a Target of Farnesoid X Receptor* , 2006, Journal of Biological Chemistry.
[75] D. Moore,et al. Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.
[76] Heidi R. Kast-Woelbern,et al. Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation* , 2003, The Journal of Biological Chemistry.
[77] B. Shneider,et al. Bile acid–induced negative feedback regulation of the human ileal bile acid transporter , 2004 .
[78] G. Casari,et al. Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol , 2003, Molecular and Cellular Biology.
[79] A. Morelli,et al. A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis , 2005, Journal of Pharmacology and Experimental Therapeutics.
[80] P. Dawson,et al. OSTα‐OSTβ: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia , 2005 .
[81] Ke Ma,et al. Farnesoid X receptor is essential for normal glucose homeostasis. , 2006, The Journal of clinical investigation.
[82] S. Nelson,et al. FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine Published, JLR Papers in Press, October 26, 2005. , 2006, Journal of Lipid Research.
[83] M. Gassull,et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats , 2003, Hepatology.
[84] T. Willson,et al. Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene , 1999, The Journal of Biological Chemistry.
[85] G. Shulman,et al. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters. , 2006, American journal of physiology. Endocrinology and metabolism.
[86] Grace Guo,et al. The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis* , 2003, The Journal of Biological Chemistry.
[87] C. Deng,et al. Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.